Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

64007957MMY4004: 64007957MMY4004 - REALiTEC

NCT06285318 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd. as lead sponsor.

NCT NCT06285318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06285318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
64007957MMY4004: 64007957MMY4004 - REALiTEC
Lead sponsor
Janssen-Cilag Ltd.
Phase
Observational
Overall status
Recruiting
Start date
December 18, 2023
Completion date
September 24, 2026
Enrollment
900 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory multiple myeloma (rrmm)